| |
| |
|
| Insider
Information: |
Soteropoulos Paula |
| Relationship: |
Chief Executive Office... |
| City: |
Peabody, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
694,147 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,386,892 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
694,147 |
|
|
| Total
Value |
$12,386,892 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -96.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
uniQure B.V. |
QURE |
Director |
2023-02-27 |
15,998 |
2018-01-26 |
0 |
Premium* |
|
|
Akcea Therapeutics Inc |
AKCA |
Chief Executive Office... |
2019-09-26 |
678,149 |
2019-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QURE |
uniQure B.V. |
Director |
– • – |
2022-11-29 |
4 |
AS |
$25.38 |
$157,356 |
D/D |
(6,200) |
16,382 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-12-09 |
4 |
AS |
$67.50 |
$168,750 |
D/D |
(2,500) |
8,352 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-04-05 |
4 |
OE |
$6.48 |
$194,400 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2020-01-07 |
4 |
AS |
$72.18 |
$216,540 |
D/D |
(3,000) |
5,352 |
0 |
% |
|
| QURE |
uniQure B.V. |
Director |
– • – |
2019-12-06 |
4 |
AS |
$63.69 |
$583,600 |
D/D |
(9,082) |
10,852 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-03-06 |
4 |
AS |
$32.14 |
$590,856 |
D/D |
(18,386) |
0 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-04-05 |
4 |
AS |
$32.11 |
$963,300 |
D/D |
(30,000) |
0 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-09-26 |
4 |
OE |
$6.48 |
$14,538,254 |
D/D |
2,061,861 |
853,213 |
0 |
- |
|
| AKCA |
Akcea Therapeutics Inc |
Chief Executive Officer |
• • – |
2019-09-26 |
4 |
D |
$16.64 |
$23,024,968 |
D/D |
(1,383,712) |
678,149 |
0 |
- |
|
34 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
